Novartis Vaccines has started shipping the first of 30 million doses of its Fluvirin® seasonal influenza vaccine to the US. The shipping has started weeks ahead of schedule. The vaccine indicated for patients aged four years and over will be used to help meet the anticipated increase in demand for the seasonal vaccine as a result of the current global (A) H1N1 swine flu pandemic.